Other diseases of liver (K76) ICD-10-CM
The K76 code range covers other diseases of liver with 15 ICD-10-CM diagnosis codes. 13 of them are billable and valid for claim submission in fiscal year 2027, and the category headers group them but cannot themselves be billed.
Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
Codes in the K76 Range 15 codes · 13 billable
- K76 Other diseases of liverNon-billable
- K76.0 Fatty (change of) liver, not elsewhere classified
- K76.1 Chronic passive congestion of liver
- K76.2 Central hemorrhagic necrosis of liver
- K76.3 Infarction of liver
- K76.4 Peliosis hepatis
- K76.5 Hepatic veno-occlusive disease
- K76.6 Portal hypertension
- K76.7 Hepatorenal syndrome
- K76.8 Other specified diseases of liverNon-billable
- K76.81 Hepatopulmonary syndrome
- K76.82 Hepatic encephalopathy
- K76.83 Intestinal failure-associated liver disease New
- K76.89 Other specified diseases of liver
- K76.9 Liver disease, unspecified
Clinical Terms in This Code Range
Definitions from the National Library of Medicine for conditions coded in the K76 range.
Central Hemorrhagic Necrosis of Liver
A disorder in which damaged or dying hepatocytes severely impair venous outflow leading to sinusoidal dilatation and hemorrhage.
Congestive Hepatopathy
Chronic passive congestion of the liver secondary to right heart failure. Elevation of central venous pressure leads to restriction of the hepatic circulation. Prolonged hepatic venous pressure may lead to liver fibrosis and cirrhosis.
Fatty Liver
Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
Hepatic Encephalopathy
A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)
Hepatic Infarction
Prolonged ischemia to the liver resulting in necrosis.
Hepatic Veno-Occlusive Disease
Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction.
Hepatopulmonary Syndrome
A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).
Hepatorenal Syndrome
Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.
Hypertension, Portal
Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
Liver Diseases
Pathological processes of the LIVER.
Peliosis Hepatis
A vascular disease of the LIVER characterized by the occurrence of multiple blood-filled CYSTS or cavities. The cysts are lined with ENDOTHELIAL CELLS; the cavities lined with hepatic parenchymal cells (HEPATOCYTES). Peliosis hepatis has been associated with use of anabolic steroids (ANABOLIC AGENTS) and certain drugs.
About the K76 Code Range
These conditions affect the liver and include fatty liver, long-term liver congestion, and liver disease associated with intestinal failure.
Under K76, subdivisions distinguish named conditions from other specified and unspecified liver disease. K76.8 divides other specified liver diseases into named syndromes, intestinal failure-associated liver disease, and other specified diseases. K76.9 identifies liver disease whose type is unspecified.
FY 2027 changes: The FY 2027 ICD-10-CM update, effective October 1, 2026, added K76.83.
Questions About This Page
How many billable codes are in the K76 range?
Of the 15 codes in this range, 13 are billable and valid for claim submission from October 1, 2026 through September 30, 2027. Category header codes group them but cannot be reported on claims.
What does the K76 range classify?
The range classifies other diseases of liver. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.
Related References
Source: CMS FY 2027 ICD-10-CM Tabular List and order file, effective October 1, 2026 through September 30, 2027.
